Akowuah Enoch

GMC: 4399885

Hospital(s): South Tees Hospitals NHS FT

Special Interests: Adult Cardiac Surgery

Enoch is one of the UKs leading cardiac surgeons. His initial medical training was at the University of Leicester where he graduated with an honours degree. He then completed a doctorate thesis at the University of Sheffield where he performed ground breaking research into the use of gene therapy to treat conditions of the heart. This research was funded by the British Heart foundation.

Enoch underwent specialist cardiac surgery training in a number of UK cardiac surgery units including Papworth Hospital in Cambridge, Sheffield, Bristol and Plymouth before moving to Melbourne Australia, for a one year advanced cardiac surgery fellowship. An award from the Society of Cardiothoracic Surgeons for Great Britain and Ireland funded this fellowship.

During this period Enoch gained specialist expertise in beating heart surgery for patients needing heart bypass surgery and keyhole techniques for patients needing a variety of heart surgery procedures.
Since he became a consultant in 2010, Enoch has become one of the most experienced keyhole heart surgeons in the UK. He travels widely both in the UK and abroad, training other surgeons trying to learn keyhole techniques for heart surgery. If you want to know more about Enoch go to enochakowuah.co.uk

Training Attended
No further information available
Qualifications & Accreditations
 

FRCS (C/Th)                         Intercollegiate Examination Board,    October 2007

 

                                                The Royal College of Surgeons      

 

Doctor of Medicine (MD)     The University of Sheffield                July 2004

                               

MRCS (London)                   The Royal College of Surgeons          June 2000

 

MBChB (with Honours)       The University of Leicester                June 1997

 

 

 
Additional Information
 

RESEARCH GRANTS

 

 

 

September 2015

 

National Institute of Healthcare Research (NIHR)

 

Awarded an HTA program grant for £1.6 Million by the NIHR, for The UK Mini Mitral Trial.

 

I am the Chief investigator with overall responsibility for the trial. This application was developed with the Research Design Service and is being conducted with the Clinical Trials Unit at Durham University.

 

This will be the world’s largest ever randomised controlled trial in minimally invasive cardiac surgery.

 

The application has the strong support of the Society for Cardiothoracic Surgeons of GB and Ireland.

 

 

   

August 2013

 

National Institute of Healthcare Research (NIHR)

Awarded an RfPB program grant for £360,000 by the NIHR, July 2013 for an RCT entitled: Manubrium-limited ministernotomy versus conventional sternotomy for aortic valve replacement: a randomised controlled trial (MAVRIC). I am the Chief investigator with overall responsibility for the trial. This application was developed with the Research Design Service is being conducted with the Clinical Trials Unit at  Durham University

Risk-adjusted in-hospital survival rate

This graph shows the “in hospital” survival rate of patients who are operated on by the individual surgeon/unit you have selected. “In hospital” means time the patient is in the hospital where they have had their operation. It does not include any time that patients may have spent in other hospitals, either before or after their heart operation.

The data has been through a complex methodology, including the variations in patient risk factors in order to give you a comparative base from which to work from. This means that the survival rates take into account the type and risk of patients being operated on for each surgeon/unit. This is known as risk adjusted survival.

The vertical axis shows the GMC number of the surgeon or the Hospital identifier. In brackets is the total number of patients operated on by the surgeon/unit and the percentage of patients for whom the survival is known. The horizontal axis is the percentage survival. The dashed vertical line shows the risk adjusted survival rate for the UK as a whole. The solid black horizontal line represents the surgeon/unit. What is important here is that the horizontal line crosses the vertical dashed line. If this occurs, it means that the surgeon/unit are within the expected outcomes given the case-mix and risk factors of the patients they operate on.

The icons that sit on the horizontal line should give you more information about your surgeon/team.

For example

The open square is the survival rate with no risk adjustments:
The X is the predicted survival with adjustments
The solid dot is the survival probability after the methodology has been applied.

  • If the solid dot is red it means survival is worse than expected
  • If the solid dot is black it means that it is within limits
  • If the solid dot is green it means that there is significantly higher survival than expected

There is a lot of information on these plots, but the takeaway message is that if the solid black line crosses the dashed vertical line then the survival rate for the surgeon/unit is within expectations and that there is no reason for any concern.

A more detailed explanation about these graphs and methodology can be found here: Graph Explanations